Stock Events

Stock Events

Aclaris Therapeutics (0H8T.LSE) Q2 2025 Earnings

8MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-1.01

-0.68

-0.34

-0.01

Details

Expected EPS

-0.152204

Actual EPS

-0.12

Surprise EPS

0.03

Surprise Percent

+21.16%

Description

Aclaris Therapeutics (0H8T.LSE) has reported earnings of -0.12 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.